Acute generalized weakness in patients referred to Amirkola Children's Hospital from 2005 to 2010

Mohammad Reza Salehiomran1, Somayeh Naserkhaki2, Mahmoud Hajiahmadi1

  • 1Non- Communicable Pediatric Diseases Research Center, Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, Iran.

Insights

Guillain-Barre syndrome is the most frequent cause of acute flaccid paralysis (AFP) in children presenting with acute generalized weakness. This finding is crucial for timely diagnosis and treatment of pediatric neurological emergencies.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Clinical Epidemiology

Background:

  • Acute flaccid paralysis (AFP) presents a diagnostic challenge due to rapid progression and potential life-threatening complications.
  • Prompt diagnosis and effective treatment are critical for managing pediatric patients with AFP.
  • This study addresses the need to identify the causes of acute generalized weakness in children.

Purpose of the Study:

  • To investigate the epidemiological causes of acute generalized weakness in children.
  • To identify the primary causes of acute flaccid paralysis in pediatric patients.
  • To inform clinical management strategies for pediatric neurological emergencies.

Main Methods:

  • A case series approach was employed to evaluate 15 pediatric cases over a five-year period (April 2005 - September 2010).
  • Data collection focused on epidemiological factors and clinical features of children presenting with acute generalized weakness.
  • Statistical analysis was performed on the collected data to determine the causes of AFP.

Main Results:

  • The study included 15 pediatric cases with a mean age of 4.7±3.5 years and a male to female ratio of 2:1.
  • Guillain-Barre syndrome was identified as the most prevalent diagnosis, accounting for 20 cases.
  • Other identified causes included myositis (2 cases) and periodic hyperkalemic paralysis (1 case).

Conclusions:

  • Guillain-Barre syndrome is the predominant cause of acute flaccid paralysis in children presenting with acute generalized weakness at Amirkola Children's Hospital.
  • These findings highlight the importance of considering Guillain-Barre syndrome in the differential diagnosis of pediatric acute weakness.
  • Early recognition and management of Guillain-Barre syndrome are essential for favorable outcomes in pediatric neurology.
Abstract

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K